Inventor · disambiguated record
Maximilian Von Eynatten
Also filed as: VON EYNATTEN MAXIMILIAN
15 granted patents·46 pending applications·139 citations·filing 2012–2025
93Inventor score
Top patents by PatentIndex Score
61 records- 0196US11833166B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Dec 5, 2023·9 cites·24 claims
- 0296US11666590B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jun 6, 2023·9 cites·32 claims
- 0396US11090323B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 17, 2021·17 cites·44 claims
- 0496US10258637B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Granted Apr 16, 2019·29 cites·24 claims
- 0596US9949998B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 24, 2018·29 cites·12 claims
- 0693US9949997B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 24, 2018·27 cites·18 claims
- 0790US11813275B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Nov 14, 2023·2 cites·7 claims
- 0890US10155000B2Medical use of pharmaceutical combination or compositionBOEHRINGER INGELHEIM INT·Filed 2017·Granted Dec 18, 2018·13 cites·23 claims
- 0988US2025025470A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1087US12427162B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Granted Sep 30, 2025·0 cites·16 claims
- 1187US11918596B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Mar 5, 2024·1 cites·12 claims
- 1287US2024299399A1Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1387US2024033270A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1482US12364700B2Medical use of pharmaceutical combination or compositionBOEHRINGER INGELHEIM INT·Filed 2023·Granted Jul 22, 2025·0 cites·18 claims
- 1582US12263153B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2022·Granted Apr 1, 2025·0 cites·30 claims
- 1681US9526730B2Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2015·Granted Dec 27, 2016·3 cites·13 claims
- 1781US2023405032A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1880US12433906B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Granted Oct 7, 2025·0 cites·41 claims
- 1980US2022226360A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2080US2024398817A1Cardio- and renosafe antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2176US2021205316A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2276US2025241887A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 2376US2021379073A1Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2473US2020338086A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2572US2018263990A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2672US2024156848A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2771US2022096505A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2871US2021228533A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2971US2014274889A1Cardio- and renoprotective antidiabetic therapyJOHANSEN ODD-ERIK·Filed 2014·Application pending·0 cites
- 3071US2020138844A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3170US2022160717A1Cardio- and Renosafe Antidiabetic TherapyBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 3269US2019192523A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 3369US2021205315A1Medical use of pharmaceutical combination or compositionBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 3469US2025345352A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 3568US2020022985A1Cardio- and renosafe antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 3668US2018125813A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 3768US2020138770A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3867US2019134072A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3966US2019099427A1Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 4065US2020171038A1Medical use of pharmaceutical combination or compositionBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4165US2016089373A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 4265US2020360412A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4365US2018169126A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 4464US2017333465A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 4563US10195203B2Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndromeBOEHRINGER INGELHEIM INT·Filed 2016·Granted Feb 5, 2019·0 cites·6 claims
- 4663US2014315832A1Pharmaceutical composition, methods for treating and uses thereofBROEDL ULI CHRISTIAN·Filed 2014·Application pending·0 cites
- 4763US2020268777A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 4862US2017065596A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 4961US2019038654A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 5060US2014303098A1Pharmaceutical composition, methods for treating and uses thereofBROEDL ULI CHRISTIAN·Filed 2014·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Maximilian Von Eynatten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →